In a large clinical trial, people taking Wegovy were less likely to die of Covid-19, with their chances of dying from the infection plunging by 33 percent.
The result suggests that lower life expectancy among people with obesity is actually caused by the disease itself, and that it can be improved by treating obesity.
The participants taking the drug were not healthier than the others, and the infection rates were similar, representing top-notch evidence.
Dr. Jeremy Faust called the data 'stunning,' highlighting the significant finding of reduced mortality among those taking Wegovy during the pandemic.
Collection
[
|
...
]